A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 478,163 shares of LLY stock, worth $372 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
478,163
Previous 495,751 3.55%
Holding current value
$372 Million
Previous $449 Million 5.62%
% of portfolio
0.98%
Previous 1.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $13.6 Million - $16.9 Million
-17,588 Reduced 3.55%
478,163 $424 Million
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $15.2 Million - $19.1 Million
-21,018 Reduced 4.07%
495,751 $449 Million
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $16.8 Million - $22.5 Million
-28,352 Reduced 5.2%
516,769 $402 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $27.6 Million - $32.5 Million
-52,512 Reduced 8.79%
545,121 $318 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $4.06 Million - $5.59 Million
-9,334 Reduced 1.54%
597,633 $321 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $2.62 Million - $3.5 Million
-7,464 Reduced 1.21%
606,967 $285 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $7.82 Million - $9.19 Million
25,179 Added 4.27%
614,431 $211 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $11.3 Million - $13.2 Million
35,245 Added 6.36%
589,252 $216 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $8.55 Million - $9.75 Million
-28,852 Reduced 4.95%
554,007 $179 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $20.4 Million - $23.9 Million
73,155 Added 14.35%
582,859 $189 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $5.48 Million - $6.82 Million
-23,368 Reduced 4.38%
509,704 $146 Million
Q4 2021

Feb 09, 2022

SELL
$224.85 - $279.04 $22.5 Million - $27.9 Million
-99,930 Reduced 15.79%
533,072 $147 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $2.14 Million - $2.63 Million
-9,647 Reduced 1.5%
633,002 $146 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $19.7 Million - $25.5 Million
-109,278 Reduced 14.53%
642,649 $147 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $26.3 Million - $34.1 Million
-160,099 Reduced 17.55%
751,927 $139 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $5.13 Million - $6.78 Million
-39,300 Reduced 4.13%
912,026 $154 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $1.99 Million - $2.31 Million
-13,634 Reduced 1.41%
951,326 $141 Million
Q2 2020

Sep 11, 2020

SELL
$136.42 - $164.18 $68.9 Million - $82.9 Million
-505,157 Reduced 34.36%
964,960 $158 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $52.7 Million - $63.4 Million
385,964 Added 35.6%
1,470,117 $158 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $4 Million - $4.96 Million
33,634 Added 3.2%
1,084,153 $150 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $3.15 Million - $3.91 Million
29,494 Added 2.89%
1,050,519 $138 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $3.81 Million - $4.15 Million
35,716 Added 3.62%
1,021,025 $115 Million
Q2 2019

Aug 07, 2019

BUY
$110.79 - $129.32 $7.28 Million - $8.5 Million
65,724 Added 7.15%
985,309 $110 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $9.06 Million - $10.7 Million
-81,429 Reduced 8.13%
919,585 $119 Million
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $6.6 Million - $7.4 Million
-62,360 Reduced 5.86%
1,001,014 $116 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $109 Million - $136 Million
-1,267,544 Reduced 54.38%
1,063,374 $114 Million
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $53,822 - $61,771
711 Added 0.03%
2,330,918 $199 Million
Q1 2018

May 11, 2018

BUY
$74.21 - $87.6 $312,349 - $368,708
4,209 Added 0.18%
2,330,207 $180 Million
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $2.47 Million - $2.65 Million
30,131 Added 1.31%
2,325,998 $196 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $177 Million - $196 Million
2,295,867
2,295,867 $196 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.